Most Significant Cureline Presentations and Publications

CPTAC Pancreatic carcinoma analysis 

CPTAC issue of CELL; Pancreatic Adenocarcinoma; 2021 Sep 16

An integrative proteogenomic portrait of lung squamous cell carcinoma

CPTAC issue of CELL; Lung Squamous Cell Carcinoma; 2021 Aug 05

Proteogenomic and metabolomic characterization of human glioblastoma

CPTAC issue of CELL; Human Glioblastoma; 2021 April 12

Proteomic characterization reveals therapeutic vulnerabilities in lung adenocarcinoma.

CPTAC Research Network. Cell 2020 July 09; 182(1):200-225.

2018 US Biopharmaceuticals REPORT

Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas.

Cell 2017 Nov 2;171(4):950-965

Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma.
Cancer Cell 2017 Aug 14; 32(2): 185-203

Integrated genomic characterization of oesophageal carcinoma.
The Cancer Genome Atlas Research Network.
NCBI 2017 Jan 12; 541(7636):169-175

Integrative, comprehensive genomic analysis of diffuse lower-grade gliomas.
The Cancer Genome Atlas Research Network.
N Engl J Med 2015 June 25; 372:2481-2498.

Genomic classification of cutaneous melanoma.
The Cancer Genome Atlas Research Network.
Cell 2015 June 18; 161(7):1681-96.

Comprehensive molecular profiling of lung adenocarcinoma.
Cancer Genome Atlas Research Network. 
Nature. 2014 Jul 31;511(7511):543-50.

Comprehensive molecular characterization of gastric adenocarcinoma.
Cancer Genome Atlas Research Network.
Nature. 2014 Sep 11;513(7517):202-9.

Integrated genomic characterization of endometrial carcinoma.
Cancer Genome Atlas Research Network.
Nature. 2013 May 2;497(7447):67-73.

Comprehensive molecular characterization of clear renal cell carcinoma.
Cancer Genome Atlas Research Network.
Nature. 2013 Jul 4;499(7456):43-9.

Meeting research needs with postmortem biospecimen donation: summary of recommendations for postmortem recovery of normal human biospecimens for research.

National Cancer Institute.
Biopreserv Biobank. 2013 Apr;11(2):77-82.

Comprehensive molecular characterization of squamous cell lung cancers.
Cancer Genome Atlas Network.
Nature. 2012 Sept 27;489(7417):519-25.

Comprehensive molecular portraits of human breast tumours.
Cancer Genome Atlas Network.
Nature. 2012 Oct 4;490(7418):61-70.

Exploring molecular pathways of triple-negative breast cancer.
Genes & Cancer. 2011 Sep;2(9):870-9.

Molecular signature and pathway analysis of human primary squamous and adenocarcinoma lung cancers.
Am J Cancer Res. 2012;2(1):93-103.

THE EFFECT OF FOLATE-RELATED SNPS ON CLINICOPATHOLOGICAL FEATURES, RESPONSE TO NEOADJUVANT TREATMENT AND SURVIVAL IN PRE- AND POSTMENOPAUSAL BREAST CANCER PATIENTS Gene. 2013, Volume 518, Issue 2
TISSUE EXPERTISE BEGAT BIOSPECIMENS CRO.Cureline’s Products Used to Create Diagnostic Tests and Also Detect Expression of Biomarkers.GEN. November 1, 2012 (Vol. 32, No. 19)
BIOSPECIMEN REPORTING FOR IMPROVED STUDY QUALITY (BRISQ)

Cancer Cytopathology. 2011

NEW TISSUE PRESERVATION TECHNOLOGIES IMPROVING COMMERCIALIZATION OF HUMAN BIOSPECIMENS

Cureline workshop at ISBER 2010 Annual Meeting

Rotterdam, Netherlands. 2010.

NEW NCI BIOBANKING PROGRAM AIMS TO BOOST QUALITY OF CANCER SPECIMENS

ONCOLOGY TIMES. 2009. Vol.31, No.22

WHY DRUG DISCOVERY NEEDS YOUR TISSUES

Interview in FUTURE PHARMACEUTICALS. Edition 1, 2006